Hospitals Immune Response Licensing Pharma Companies 
Drug Discovery World
MAY 6, 2024
In Paris itself, Institut Curie is a major cancer hospital, from which One Biosciences was spun-off. The transfer of technologies from the lab to the market, is no longer purely via IP out licensing, but rather via start-up M&A deals – start-ups being the de-risking vehicle for large corporates.
Drug Discovery World
APRIL 20, 2023
SARS-CoV-2 particles spread through the respiratory mucosa and other infected cells, causing changes in peripheral immune cells and eliciting a cascade of immune responses, resulting in a detrimental cytokine storm. Acute and persistent symptoms in non-hospitalized PCR- confirmed COVID-19 patients,” Sci Rep, vol.
Codon
FEBRUARY 13, 2024
Phage-based products have been licensed for use as antibacterial agents in the sanitation , food production , and animal health industries. Crucially, it could also make them easier to license as therapeutic agents. There is also a growing body of successful treatments in the U.S., 4 But the same barriers still exist today.
Expert insights. Personalized for you.
147 
Let's personalize your content